1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,670 | 2,790 | 19:04 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.06. | Careium AB: Bulletin from the extraordinary general meeting on 13 June 2025 of Careium AB (publ) | 79 | GlobeNewswire (Europe) | The extraordinary general meeting ("EGM") of Careium AB (publ), 559121-5875, (the "Company") took place today, 13 June 2025.
The EGM resolved on all proposed matters in accordance with previously published... ► Artikel lesen | |
| CAREIUM Aktie jetzt für 0€ handeln | |||||
| 24.04. | Careium AB: Careium reports first quarter results 2025 | 41 | GlobeNewswire (Europe) | The First Quarter in Summary
Net sales decreased 1.6 percent to SEK 207.4 million (210.7)Service sales increased 3.4 percent to SEK 160.3 million (155.0)Product sales decreased 15.5 percent to SEK 47.1... ► Artikel lesen | |
| 13.02. | Careium AB: Careium reports fourth quarter results 2024 | 441 | GlobeNewswire (Europe) | The Fourth Quarter in SummaryNet sales increased 14.8 percent to SEK 228.9 million (199.4)Service sales was SEK 165.9 million (154.1)Product sales was SEK 63.0 million (45.3)Gross margin increased to... ► Artikel lesen | |
| 25.10.24 | Careium AB: Careium reports third quarter results 2024 | 164 | GlobeNewswire (Europe) | The quarter in summary
Net sales amounted to SEK 201.7 million (217.3), a decrease of 7.2 percent, as sales cycles were affected by prolonged lifetime of analog (UK) and 2G/3G (SWE) networks
Service... ► Artikel lesen | |
| 13.09.24 | Careium AB: Careium revises full-year outlook due to infrastructure transition delays in the UK and Sweden | 184 | GlobeNewswire (Europe) | Careium, the European champion in technology enabled care, has revised its full-year growth outlook downward due to infrastructure transition delays affecting its business more than expected, and it... ► Artikel lesen | |
| 12.07.24 | Careium AB: Careium reports second quarter results 2024 | 171 | GlobeNewswire (Europe) | The quarter in summary
Net sales amounted to SEK 229.4 million (213.8), an increase of 7.3 percent. Service sales amounted to 163.3 million (158.9), an increase of 2.8 percent. Product sales amounted... ► Artikel lesen |
6 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 42,480 | +0,21 % | Aktie von Fresenius SE & Co. KGaA: Kurs heute nahezu konstant (42,73 €) | Die Wertschätzung für den Anteilsschein von Fresenius SE & Co. KGaA hat sich am Aktienmarkt heute kaum geändert. Das Wertpapier notiert zur Stunde bei 42,73 Euro. Kaum auffällig ist derzeit an der Börse... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,730 | -0,43 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 53,60 | -0,46 % | GOLDMAN SACHS stuft CARL ZEISS MEDITEC AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Carl Zeiss Meditec von 77 auf 74 Euro gesenkt, aber die Einstufung auf "Buy" belassen. Das dritte Geschäftsquartal... ► Artikel lesen | |
| ECKERT & ZIEGLER | 66,40 | -0,60 % | Eckert&Ziegler mit BLITZMELDUNG: Könnte die Aktie am Montag komplett einbrechen - Experten empfehlen SOFORT zu handeln! | ||
| THERMO FISHER | 366,00 | +0,10 % | Here's What to Expect From Thermo Fisher Scientific's Next Earnings Report | ||
| STRATEC | 26,850 | -0,37 % | Dividendenbekanntmachungen (30.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIA REALTY TRUST US0042391096 0,2 USD 0,1706 EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1808 EUR ADVANCED FLOWER CAPITAL... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 60,62 | -0,03 % | Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 June 2025 | Regulatory News:
Eurofins Scientific SE (Paris:ERF):
ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | SYNLAB AG: Zurückziehung - 01.07.2025 | ||
| DAVITA | 120,00 | -0,29 % | DaVita: Frank's Team Shows They Care During His Time of Need | NORTHAMPTON, MA / ACCESS Newswire / July 3, 2025 / Frank's teammates really stepped up during his time of need and showed they genuinely care about him. That's the DaVita Difference.About DaVita Inc.DaVita... ► Artikel lesen | |
| DENTSPLY SIRONA | 13,980 | -0,60 % | DENTSPLY SIRONA Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| SMITH & NEPHEW | 13,035 | +0,58 % | Smith & Nephew UK Ltd: Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair | Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces it will once again support select players during high profile matches at The Championships, Wimbledon in 2025. The world's... ► Artikel lesen | |
| SONIC HEALTHCARE | 15,186 | +0,92 % | SONIC HEALTHCARE LIMITED: Settlement of the Acquisition of the LADR Laboratory Group | ||
| DIASORIN | 90,36 | +0,42 % | Dividendenbekanntmachungen (21.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AFLAC INC US0010551028 0,58 USD 0,5141 EUR ARCHER DANIELS MIDLAND COMPANY US0394831020 0,51 USD 0,452 EUR ASSECO BUSINESS SOLUTIONS... ► Artikel lesen | |
| PATTERSON COMPANIES | 27,400 | 0,00 % | Patterson Companies Completes Acquisition by Patient Square Capital | Robert Rajalingam Appointed Chief Executive Officer and to Board of Directors
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies ("Patterson" or the "Company"), a leading supplier of products... ► Artikel lesen | |
| FULGENT GENETICS | 17,100 | +1,18 % | Fulgent genetics targets $310M core revenue in 2025 with strong growth in diagnostics and pathology |
Das Unternehmen CAREIUM AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 2,680 Euro und damit -2,19 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CAREIUM AB finden Sie auf Wallstreet Online.